Redefining periodic paralysis with CACNA1S mutation in a Spanish cohort
P Carbonell-Corvillo1, E Rivas2, M Cabrera3
1Neuromuscular Disorders Unit, Department of Neurology, Hospital Universitario Virgen del Rocío/Instituto de Biomedicina de Sevilla (IBiS)/CSIC/Universidad de Sevilla, Seville, Spain; Department of Neurology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
Muscle MRI and exercise testing reveal muscle alterations in hypokalemic periodic paralysis (HypoPP) carriers, even those without symptoms. These findings highlight their utility as screening tools for this genetic disorder.
Area of Science:
- Neurology
- Genetics
- Musculoskeletal Disorders
Background:
- Hypokalemic periodic paralysis (HypoPP) diagnosis often relies on muscle MRI and electrophysiological testing.
- Clinical presentation varies significantly between sexes, but data on asymptomatic individuals are limited.
Purpose of the Study:
- To investigate muscle MRI and electrophysiological exercise test findings in symptomatic and asymptomatic carriers of the p.R528H CACNA1S mutation in HypoPP.
- To assess the utility of these tests as screening tools in a homogeneous cohort.
Main Methods:
- Recruited 11 individuals with HypoPP from 4 families (p.R528H CACNA1S mutation), including 8 symptomatic men and 3 asymptomatic women, plus 9 controls.
- Evaluated muscle MRI and electrophysiological long exercise test results in this cohort.
Main Results:
- Muscle MRI revealed atrophy and fatty infiltration in posterior thigh muscles (adductor magnus, semimembranosus) in all carriers, correlating with age.
- Long exercise test showed delayed compound muscle action potential decrement in all carriers, irrespective of symptoms.
- Test sensitivity reached 100% after 35 minutes of exercise.
Conclusions:
- Muscle MRI and exercise testing findings are consistent between symptomatic and asymptomatic HypoPP carriers with the p.R528H mutation.
- These non-invasive tests are valuable screening tools for identifying affected individuals, including those without clinical symptoms.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
04:41Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research
Published on: October 13, 2023
Related Concept Videos
Animal Mitochondrial Genetics
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Huntington Disease l: Introduction
